🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a multi-centre, randomised, double-blind, placebo-controlled ...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-10-01
Trial ID
NCT02567708
Treatments Being Tested
GSK2269557 is being developed as an anti-inflammatory and anti-infective ag...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-06-15
Trial ID
NCT03189589
Treatments Being Tested
GSK2269557 is a potent and highly selective inhaled Phosphoinositide 3-Kina...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-10
Trial ID
NCT02972905
Treatments Being Tested
GSK2269557 is a potent and highly selective inhaled Phosphoinositide 3-Kina...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-03-14
Trial ID
NCT02691325
Treatments Being Tested
GSK2269557 is being developed as an anti-inflammatory agent for the treatme...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-11-14
Trial ID
NCT03315559
Treatments Being Tested